{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:12:37Z","timestamp":1794964357642,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41565-021-00961-w","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T16:43:47Z","timestamp":1632415427000},"page":"1251-1259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application"],"prefix":"10.1038","volume":"16","author":[{"given":"Poulami","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1402-9934","authenticated-orcid":false,"given":"Kingshuk","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-7155","authenticated-orcid":false,"given":"Nimit L.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"de Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T. R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Byungyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktiar","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-1434","authenticated-orcid":false,"given":"Chuong D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4403-7900","authenticated-orcid":false,"given":"Joel P.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"961_CR1","doi-asserted-by":"publisher","first-page":"208ra147","DOI":"10.1126\/scitranslmed.3006941","volume":"5","author":"R Hassan","year":"2013","unstructured":"Hassan, R. et al. Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression. Sci. Transl. Med. 5, 208ra147 (2013).","journal-title":"Sci. Transl. Med."},{"key":"961_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1056\/NEJM195505262522103","volume":"252","author":"JH Fisher","year":"1955","unstructured":"Fisher, J. H. & Child, C. G. 3rd Myasthenia gravis developing acutely after partial removal of a thymoma. N. Engl. J. Med. 252, 891\u2013893 (1955).","journal-title":"N. Engl. J. Med."},{"key":"961_CR3","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","volume":"38","author":"T Motohara","year":"2019","unstructured":"Motohara, T. et al. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene 38, 2885\u20132898 (2019).","journal-title":"Oncogene"},{"key":"961_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41556-017-0027-6","volume":"20","author":"O Zajac","year":"2018","unstructured":"Zajac, O. et al. Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas. Nat. Cell Biol. 20, 296\u2013306 (2018).","journal-title":"Nat. Cell Biol."},{"key":"961_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","volume":"13","author":"R Bueno","year":"2018","unstructured":"Bueno, R., Opitz, I. & Taskforce, I. M. Surgery in malignant pleural mesothelioma. J. Thorac. Oncol. 13, 1638\u20131654 (2018).","journal-title":"J. Thorac. Oncol."},{"key":"961_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe, G. I. et al. Randomized trial of thymectomy in myasthenia gravis. N. Engl. J. Med. 375, 511\u2013522 (2016).","journal-title":"N. Engl. J. Med."},{"key":"961_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-15-1620","volume":"76","author":"KRK Winner","year":"2016","unstructured":"Winner, K. R. K. et al. Spatial modeling of drug delivery routes for treatment of disseminated ovarian cancer. Cancer Res. 76, 1320\u20131334 (2016).","journal-title":"Cancer Res."},{"key":"961_CR8","doi-asserted-by":"crossref","unstructured":"Jacquet, P. et al. in Peritoneal Carcinomatosis: Principles of Management. Vol. 82 (ed. Sugarbaker, P. H.) 53\u201363 (Springer, 1996).","DOI":"10.1007\/978-1-4613-1247-5_4"},{"key":"961_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum, D., Joshi, N., Tao, W., Karp, J. M. & Peer, D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9, 1410 (2018).","journal-title":"Nat. Commun."},{"key":"961_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838 (2005).","journal-title":"Nature"},{"key":"961_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16, 203\u2013222 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"961_CR12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling, H., Fabbri, M. & Calin, G. A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12, 847\u2013865 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"961_CR13","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman, G. et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 387, 1405\u20131414 (2016).","journal-title":"Lancet"},{"key":"961_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","volume":"149","author":"EH Baldini","year":"2015","unstructured":"Baldini, E. H. et al. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 149, 1374\u20131381 (2015).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"961_CR15","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.21037\/jtd.2017.10.165","volume":"10","author":"P Bertoglio","year":"2018","unstructured":"Bertoglio, P., Aprile, V., Ambrogi, M. C., Mussi, A. & Lucchi, M. The role of intracavitary therapies in the treatment of malignant pleural mesothelioma. J. Thorac. Dis. 10, S293\u2013S297 (2018).","journal-title":"J. Thorac. Dis."},{"key":"961_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejcts.2006.11.046","volume":"31","author":"M Lucchi","year":"2007","unstructured":"Lucchi, M. et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy\/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur. J. Cardiothorac. Surg. 31, 529\u2013533 (2007).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"961_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biomaterials.2016.06.031","volume":"102","author":"R Liu","year":"2016","unstructured":"Liu, R. et al. Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma. Biomaterials 102, 175\u2013186 (2016).","journal-title":"Biomaterials"},{"key":"961_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.semtcvs.2016.02.010","volume":"28","author":"E Taioli","year":"2016","unstructured":"Taioli, E. et al. Second primary lung cancers demonstrate better survival with surgery than radiation. Semin. Thorac. Cardiovasc. Surg. 28, 195\u2013200 (2016).","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"961_CR19","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","volume":"27","author":"A Singh","year":"2019","unstructured":"Singh, A. et al. MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis. Mol. Ther. 27, 1665\u20131680 (2019).","journal-title":"Mol. Ther."},{"key":"961_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.omtn.2021.04.001","volume":"24","author":"A Singh","year":"2021","unstructured":"Singh, A. et al. microRNA-206 suppresses mesothelioma progression via the Ras signaling axis. Mol. Ther. Nucleic Acids 24, 669\u2013681 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"961_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","volume":"18","author":"N van Zandwijk","year":"2017","unstructured":"van Zandwijk, N. et al. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol. 18, 1386\u20131396 (2017).","journal-title":"Lancet Oncol."},{"key":"961_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno, R. et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat. Genet. 48, 407\u2013416 (2016).","journal-title":"Nat. Genet."},{"key":"961_CR23","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1378\/chest.12-2770","volume":"144","author":"Y Xu","year":"2013","unstructured":"Xu, Y. et al. miR-1 induces growth arrest and apoptosis in malignant mesothelioma. Chest 144, 1632\u20131643 (2013).","journal-title":"Chest"},{"key":"961_CR24","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1021\/acsami.7b19183","volume":"10","author":"X Cui","year":"2018","unstructured":"Cui, X. et al. Enhanced chemotherapeutic efficacy of paclitaxel nanoparticles co-delivered with MicroRNA-7 by inhibiting paclitaxel-induced EGFR\/ERK pathway activation for ovarian cancer therapy. ACS Appl. Mater. Interfaces 10, 7821\u20137831 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"961_CR25","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1038\/onc.2014.282","volume":"34","author":"AL Kasinski","year":"2015","unstructured":"Kasinski, A. L. et al. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene 34, 3547\u20133555 (2015).","journal-title":"Oncogene"},{"key":"961_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","volume":"81","author":"Y Chen","year":"2015","unstructured":"Chen, Y., Gao, D. Y. & Huang, L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv. Drug Deliv. Rev. 81, 128\u2013141 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"961_CR27","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41551-017-0157-y","volume":"1","author":"LL Wang","year":"2017","unstructured":"Wang, L. L. et al. Local and sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischemic injury. Nat. Biomed. Eng. 1, 983\u2013992 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"961_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10376","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang, X., Li, Y., Chen, Y. E., Chen, J. & Ma, P. X. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects. Nat. Commun. 7, 10376 (2016).","journal-title":"Nat. Commun."},{"key":"961_CR29","doi-asserted-by":"publisher","first-page":"e1902232","DOI":"10.1002\/smll.201902232","volume":"15","author":"B Saleh","year":"2019","unstructured":"Saleh, B. et al. Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing. Small 15, e1902232 (2019).","journal-title":"Small"},{"key":"961_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nmat4497","volume":"15","author":"J Conde","year":"2016","unstructured":"Conde, J., Oliva, N., Atilano, M., Song, H. S. & Artzi, N. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment. Nat. Mater. 15, 353\u2013363 (2016).","journal-title":"Nat. Mater."},{"key":"961_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12868","volume":"7","author":"A Gilam","year":"2016","unstructured":"Gilam, A. et al. Local microRNA delivery targets Palladin and prevents metastatic breast cancer. Nat. Commun. 7, 12868 (2016).","journal-title":"Nat. Commun."},{"key":"961_CR32","doi-asserted-by":"publisher","first-page":"9816","DOI":"10.1073\/pnas.1509313112","volume":"112","author":"K Nagy-Smith","year":"2015","unstructured":"Nagy-Smith, K., Moore, E., Schneider, J. & Tycko, R. Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network. Proc. Natl Acad. Sci. USA 112, 9816\u20139821 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"961_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41565-019-0512-0","volume":"14","author":"J Conniot","year":"2019","unstructured":"Conniot, J. et al. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nat. Nanotechnol. 14, 891\u2013901 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"961_CR34","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","volume":"14","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Nat. Nanotechnol. 14, 974\u2013980 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"961_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1226338","volume":"338","author":"Z Cheng","year":"2012","unstructured":"Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338, 903\u2013910 (2012).","journal-title":"Science"},{"key":"961_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13580","volume":"7","author":"K Ren","year":"2016","unstructured":"Ren, K. et al. A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery. Nat. Commun. 7, 13580 (2016).","journal-title":"Nat. Commun."},{"key":"961_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtn.2017.04.015","volume":"7","author":"W Chen","year":"2017","unstructured":"Chen, W., Deng, W. & Goldys, E. M. Light-triggerable liposomes for enhanced endolysosomal escape and gene silencing in PC12 cells. Mol. Ther. Nucleic Acids 7, 366\u2013377 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"961_CR38","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1021\/acsnano.9b05521","volume":"13","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Metal-phenolic coatings as a platform to trigger endosomal escape of nanoparticles. ACS Nano 13, 11653\u201311664 (2019).","journal-title":"ACS Nano"},{"key":"961_CR39","doi-asserted-by":"publisher","first-page":"E4904","DOI":"10.1073\/pnas.1302334110","volume":"110","author":"EJ Gillespie","year":"2013","unstructured":"Gillespie, E. J. et al. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc. Natl Acad. Sci. USA 110, E4904\u2013E4912 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"961_CR40","doi-asserted-by":"publisher","first-page":"L652","DOI":"10.1152\/ajplung.00141.2020","volume":"319","author":"N Pruett","year":"2020","unstructured":"Pruett, N., Singh, A., Shankar, A., Schrump, D. S. & Hoang, C. D. Normal mesothelial cell lines newly derived from human pleural biopsy explants. Am. J. Physiol. Lung Cell. Mol. Physiol. 319, L652\u2013L660 (2020).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"961_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acscentsci.7b00115","volume":"3","author":"K Nagy-Smith","year":"2017","unstructured":"Nagy-Smith, K. et al. Molecular, local, and network-level basis for the enhanced stiffness of hydrogel networks formed from coassembled racemic peptides: predictions from Pauling and Corey. ACS Cent. Sci. 3, 586\u2013597 (2017).","journal-title":"ACS Cent. Sci."},{"key":"961_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2016.05.056","volume":"235","author":"B Sun","year":"2016","unstructured":"Sun, B. et al. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals. J. Control. Release 235, 91\u201398 (2016).","journal-title":"J. Control. Release"},{"key":"961_CR43","doi-asserted-by":"publisher","first-page":"E8388","DOI":"10.1073\/pnas.1805751115","volume":"115","author":"GM Shankar","year":"2018","unstructured":"Shankar, G. M. et al. Genotype-targeted local therapy of glioma. Proc. Natl Acad. Sci. USA 115, E8388\u2013E8394 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"961_CR44","unstructured":"National Research Council Guide for Care and Use of Laboratory Animals (National Academies Press, 2011)."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00961-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00961-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T16:09:53Z","timestamp":1675699793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-021-00961-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["961"],"URL":"https:\/\/doi.org\/10.1038\/s41565-021-00961-w","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.S., P.M., C.D.H. and A.S. have filed a patent covering this work. All the other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}